BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24974847)

  • 1. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.
    Fachal L; Gómez-Caamaño A; Barnett GC; Peleteiro P; Carballo AM; Calvo-Crespo P; Kerns SL; Sánchez-García M; Lobato-Busto R; Dorling L; Elliott RM; Dearnaley DP; Sydes MR; Hall E; Burnet NG; Carracedo Á; Rosenstein BS; West CM; Dunning AM; Vega A
    Nat Genet; 2014 Aug; 46(8):891-4. PubMed ID: 24974847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
    Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
    Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
    Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
    EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity.
    Fachal L; Mosquera-Miguel A; Gómez-Caamaño A; Sánchez-García M; Calvo P; Lobato-Busto R; Salas A; Vega A
    Radiother Oncol; 2014 May; 111(2):199-205. PubMed ID: 24746576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.
    Ahmed M; Dorling L; Kerns S; Fachal L; Elliott R; Partliament M; Rosenstein BS; Vega A; Gómez-Caamaño A; Barnett G; Dearnaley DP; Hall E; Sydes M; Burnet N; Pharoah PD; Eeles R; West CM
    Br J Cancer; 2016 May; 114(10):1165-74. PubMed ID: 27070714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.
    Kerns SL; Ostrer H; Stock R; Li W; Moore J; Pearlman A; Campbell C; Shao Y; Stone N; Kusnetz L; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1292-300. PubMed ID: 20932654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding the genetic determinants of adverse reactions to radiotherapy.
    Rattay T; Talbot CJ
    Clin Oncol (R Coll Radiol); 2014 May; 26(5):301-8. PubMed ID: 24702740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
    Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
    Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
    Barnett GC; Coles CE; Elliott RM; Baynes C; Luccarini C; Conroy D; Wilkinson JS; Tyrer J; Misra V; Platte R; Gulliford SL; Sydes MR; Hall E; Bentzen SM; Dearnaley DP; Burnet NG; Pharoah PD; Dunning AM; West CM
    Lancet Oncol; 2012 Jan; 13(1):65-77. PubMed ID: 22169268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.
    Kerns SL; Stone NN; Stock RG; Rath L; Ostrer H; Rosenstein BS
    J Urol; 2013 Jul; 190(1):102-8. PubMed ID: 23376709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury.
    Wang TM; Shen GP; Chen MY; Zhang JB; Sun Y; He J; Xue WQ; Li XZ; Huang SY; Zheng XH; Zhang SD; Hu YZ; Qin HD; Bei JX; Ma J; Mu J; Yao Shugart Y; Jia WH
    J Natl Cancer Inst; 2019 Jun; 111(6):620-628. PubMed ID: 30299488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
    Andreassen CN; Rosenstein BS; Kerns SL; Ostrer H; De Ruysscher D; Cesaretti JA; Barnett GC; Dunning AM; Dorling L; West CML; Burnet NG; Elliott R; Coles C; Hall E; Fachal L; Vega A; Gómez-Caamaño A; Talbot CJ; Symonds RP; De Ruyck K; Thierens H; Ost P; Chang-Claude J; Seibold P; Popanda O; Overgaard M; Dearnaley D; Sydes MR; Azria D; Koch CA; Parliament M; Blackshaw M; Sia M; Fuentes-Raspall MJ; Ramon Y Cajal T; Barnadas A; Vesprini D; Gutiérrez-Enríquez S; Mollà M; Díez O; Yarnold JR; Overgaard J; Bentzen SM; Alsner J;
    Radiother Oncol; 2016 Dec; 121(3):431-439. PubMed ID: 27443449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.
    Seibold P; Behrens S; Schmezer P; Helmbold I; Barnett G; Coles C; Yarnold J; Talbot CJ; Imai T; Azria D; Koch CA; Dunning AM; Burnet N; Bliss JM; Symonds RP; Rattay T; Suga T; Kerns SL; Bourgier C; Vallis KA; Sautter-Bihl ML; Claßen J; Debus J; Schnabel T; Rosenstein BS; Wenz F; West CM; Popanda O; Chang-Claude J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1084-1092. PubMed ID: 26072091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
    Kerns SL; Stock R; Stone N; Buckstein M; Shao Y; Campbell C; Rath L; De Ruysscher D; Lammering G; Hixson R; Cesaretti J; Terk M; Ostrer H; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e21-8. PubMed ID: 23021708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.
    Schack LMH; Petersen SE; Nielsen S; Lundby L; Høyer M; Bentzen L; Overgaard J; Andreassen CN; Alsner J
    Acta Oncol; 2017 Nov; 56(11):1514-1521. PubMed ID: 28844157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.
    Takata R; Akamatsu S; Kubo M; Takahashi A; Hosono N; Kawaguchi T; Tsunoda T; Inazawa J; Kamatani N; Ogawa O; Fujioka T; Nakamura Y; Nakagawa H
    Nat Genet; 2010 Sep; 42(9):751-4. PubMed ID: 20676098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
    Duan L; Wei L; Tian Y; Zhang Z; Hu P; Wei Q; Liu S; Zhang J; Wang Y; Li D; Yang W; Zong R; Xian P; Han C; Bao X; Zhao F; Feng J; Liu W; Cao W; Zhou G; Zhu C; Yu F; Yang W; Meng Y; Wang J; Chen X; Wang Y; Shen B; Zhao B; Wan J; Zhang F; Zhao G; Xu A; Zhang X; Liu J; Zuo X; Wang K
    Stroke; 2018 Jan; 49(1):11-18. PubMed ID: 29273593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.
    Langsenlehner T; Renner W; Gerger A; Hofmann G; Thurner EM; Kapp KS; Langsenlehner U
    Strahlenther Onkol; 2011 Dec; 187(12):784-91. PubMed ID: 22105769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association studies and prediction of normal tissue toxicity.
    West CM; Dunning AM; Rosenstein BS
    Semin Radiat Oncol; 2012 Apr; 22(2):91-9. PubMed ID: 22385916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.